Despite the high stakes, more than half of boards and CEOs are not confident their succession planning is adequate.

How pharma and biotech leaders can navigate today’s challenging landscape—focusing on revamped approaches in business operations, talent strategy and development, and more to meet the evolving demands.

Outlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.

Organizations need a future-back approach to identifying potential, including simulations and key assessment methods, that goes beyond standard performance reviews.

The highest-performing teams steward conversation through three elements: goals, roles, and soul. Use this framework for greater clarity, stronger trust, and better decisions.

How moments-based simulations and AI role-play help leaders practice high-stakes conversations, build real behavior change, and give L&D predictive insight into performance.